Skip to main content
SpringerLink
Log in

The Dysplastic Nevus Syndrome

  • Chapter
Skin Cancer

  • 184 Accesses

Abstract

The dysplastic nevus (DN) is a special kind of atypical melanocytic nevus with clinical and histologic features suggestive of an intermediate form between the common acquired melanocytic nevus and melanoma (1). Dysplastic nevi are important markers for both familial and nonfamilial melanoma. About 50% of patients with “sporadic” melanoma have been observed to have dysplastic nevi (2–5). Patients with dysplastic nevus syndrome (DNS) may also be at increased risk of conjunctival and intraocular melanoma (6). The incidence of DN in the general population has been estimated to be 1.8–7% (7–9) and possibly as high as 20% (10).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kelly JW, Crutcher WA, Sagebiel RW: Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation. J Am Acad Dermatol 1986; 14:1044–1052.

    Article  PubMed  CAS  Google Scholar 

  2. Holly EA, Kelly JW, Shpall SN, Chiu S-H: Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17: 459–468.

    Article  PubMed  CAS  Google Scholar 

  3. Kraemer KH, Tucker M, Tarone R, et al: Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B. N Engl J Med 1986; 315:1615–1616.

    Article  PubMed  CAS  Google Scholar 

  4. Clark WH, Reimer RR, Greene MH, et al: Origin of familial malignant melanoma from heritable melanocytic lesions: The B-K mole syndrome. Arch Dermatol 1978; 114:732–738.

    Article  PubMed  Google Scholar 

  5. Crutcher WA, Sagebiel RW: The significance of a small, solitary atypical mole. Fitzpatrick Festschrift, Harvard Medical School Symposium, Sept. 13, 1982.

    Google Scholar 

  6. Friedman RJ, Rodriguez-Sains R, Jakobiec F: Conjunctival malignant melanoma in association with sporadic dysplastic nevus syndrome. J Dermatol Surg Oncol 1987; 13:31–34.

    PubMed  CAS  Google Scholar 

  7. Crutcher WA, Sagebiel RW: Prevalence of dysplastic nevi in a community practice. Lancet 1984; 1:729.

    Article  PubMed  CAS  Google Scholar 

  8. Scheibner A, Milton GW, McCarthy WH, et al: Clinical features, prognosis and incidence of multiple primary malignant melanoma. Aust NZ J Surg 1981; 51:386.

    Article  Google Scholar 

  9. Nordlund JJ, Kirwood J, Forget BM, et al: Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985; 45:1855–1861.

    PubMed  CAS  Google Scholar 

  10. Meyer LJ, Zone JJ, Piepkorn DT, et al: The dysplastic nevus syndrome: Clinical variation among members of large families. Clin Res 1987; 35:389A.

    Google Scholar 

  11. Greene MH, Clark WH, Tucker MA, et al: Acquired precursors of cutaneous malignant melanoma. N Engl J Med 1985; 312:91–97.

    Article  PubMed  CAS  Google Scholar 

  12. Bale SJ, Chakravarti A, Greene MH: Cutaneous malignant melanoma and familial dysplastic nevi: Evidence for autosomal dominance and pleiotrophy. Am J Hum Genet 1986; 38:188–196.

    PubMed  CAS  Google Scholar 

  13. Greene MH, Goldin LR, Clark WH Jr, et al: Familial cutaneous malignant melanoma: Autosomal dominant trait possibly linked with the Rh locus. Proc Natl Acad Sci USA 1983; 80:6071–6075.

    Article  PubMed  CAS  Google Scholar 

  14. Frichot BC, Lynch HT: A new cutaneous phenotype in familial malignant melanoma. Lancet 1977; 1:864–865.

    Article  PubMed  Google Scholar 

  15. Kraemer KH, Greene MH, Tarone R, et al: Dysplastic naevi and cutaneous melanoma risk. Lancet 1983; 2:1076–1077.

    Article  PubMed  CAS  Google Scholar 

  16. Kraemer KH, Greene MH: Dysplastic nevus syndrome: Familial and sporadic precursors of cutaneous melanoma. Dermatol Clin 1985; 3:225–237.

    Article  PubMed  CAS  Google Scholar 

  17. Norris W: A case of fungoid disease. Edinburgh Med Surg J 1820; 16:562–565.

    Google Scholar 

  18. Munro DD: Multiple active junctional nevi with family history of malignant melanoma. Proc R Soc Med 1974; 67:594–595.

    PubMed  CAS  Google Scholar 

  19. Lynch HT, Frichot BC, Lynch JF: Familial atypical multiple mole-melanoma syndrome. J Med Genet 1978; 15:352–356.

    Article  PubMed  CAS  Google Scholar 

  20. Elder DE, Goldman LI, Goldman SC, et al: The large atypical nevus syndrome: A phenotypic association of malignant melanoma. Cancer 1980; 46:73–80.

    Article  Google Scholar 

  21. Elder DE, Goldman LI, Goldman SC, et al: Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanoma. Cancer 1980; 46: 1787–1794.

    Article  PubMed  CAS  Google Scholar 

  22. Rahbari H, Mehregan AH: Sporadic atypical mole syndrome. Arch Dermatol 1981; 117:329–331.

    Article  PubMed  CAS  Google Scholar 

  23. Fusaro RM, Lynch HT, Kimberling WJ: Familial atypical multiple mole melanoma syndrome (FAMMM). Arch Dermatol 1983; 119:2–3.

    Article  PubMed  CAS  Google Scholar 

  24. Jung EG, Bohnert E, Boonen H: Dysplastic nevus syndrome: Ultraviolet hypermuĩability confirmed in vitro by elevated sister chromatid exchanges. Dermatologica 1986; 173:297–300.

    Article  PubMed  CAS  Google Scholar 

  25. Caporaso N, Greene MH, Tsai S, et al: Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: Is dysplastic nevus syndrome a chromosome instability disorder? Cancer Genet Cytogenet 1987; 24:299–314.

    Article  PubMed  CAS  Google Scholar 

  26. Jaspers NGJ, Roza-de Jongh EJM, Donselaar IG, et al: Sister chromatid exchanges, hyperdiploidy and chromosomal rearrangements studied in cells from melanoma-prone individuals belonging to families with the dysplastic nevus syndrome. Cancer Genet Cytogenet 1987; 24:33–43.

    Article  PubMed  CAS  Google Scholar 

  27. Bale SJ, Greene MH, Lovrein E: Hereditary melanoma, the dysplastic nevus syndrome, and transferrin. Cancer Genet Cytogenet 1986; 23:279–280.

    Article  PubMed  CAS  Google Scholar 

  28. Sutherland C, Shaw HM, Roberts C, et al: Harveyras oncogene restriction fragment alleles in familial melanoma kindreds. Br J Cancer 1986; 54:787–790.

    Article  PubMed  CAS  Google Scholar 

  29. Takahashi H, Horikoshi T, Jimbow K: Fine structural changes of melanogenesis in intraepidermal atypical melanocytic hyperplasia of dysplastic nevus syndrome, in Bagnara J, Klaus SN, Paul E, Schartl M (Eds): Pigment Cell 1985. Tokyo, University of Tokyo Press, 1985, pp 673–682.

    Google Scholar 

  30. Clark WH Jr, Elder DE, Guerry DuP IV, et al: A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15:1147–1165.

    Article  PubMed  Google Scholar 

  31. Crutcher W, Epstein W: Clinical characteristics and management of dysplastic nevi. National Institutes of Health Consensus Development Conference: Precursors to Malignant Melanoma. Conference Abstracts, Oct. 24–26, 1983.

    Google Scholar 

  32. Rhodes AR, Harrist TJ, Day CL, et al: Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol 1983; 9:563–574.

    Article  PubMed  CAS  Google Scholar 

  33. Ackerman AB, Mihara I: Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanoma. Hum Pathol 1985; 16:87–91.

    Article  PubMed  CAS  Google Scholar 

  34. Seywright MM, Doherty VR, MacKie R: Proposed alternative terminology and subclassification of so called “dysplastic naevi.” J Clin Pathol 1986; 39:189–194.

    Article  PubMed  CAS  Google Scholar 

  35. Elder DE, Greene MH, Bondi EE, et al: Acquired melanocytic nevi and melanoma: The dysplastic nevus syndrome, in Ackerman AB (Ed): Pathology of Malignant Melanoma. New York, Masson, 1981, pp 185–215.

    Google Scholar 

  36. Sagebiel RW: Histopathology of precursor melanocytic lesions. Am J Surg Pathol 1985; 9 (Suppl): 41–52, 1985.

    Google Scholar 

  37. Rhodes AR, Harrist TJ, Mihm MC Jr, et al: Dysplastic nevi in histologic association with 234 cutaneous melanomas. Lab Invest 1982; 46:69A.

    Google Scholar 

  38. Sagebiel RW, Banda PW, Schneider JS, Crutcher WA: Age distribution and histologic patterns of dysplastic nevi. J Am Acad Dermatol 1985; 13:975–982.

    Article  PubMed  CAS  Google Scholar 

  39. Rhodes AR, Melski JW, Sober AJ, et al: Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma: A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigenes. J Invest Dermatol 1983; 80:452–459.

    Article  PubMed  CAS  Google Scholar 

  40. Swerdlow AJ, English J, MacKie RM: Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986; 292:1555–1559.

    Article  CAS  Google Scholar 

  41. Crutcher WA: Undressing dermatology patients: Round 2. J Am Acad Dermatol 1986; 14:135–137.

    Article  Google Scholar 

  42. Reimer RR, Clark WH Jr, Greene MH, et al: Precursor lesions in familial melanoma. JAMA 1978; 239:744–746.

    Article  PubMed  CAS  Google Scholar 

  43. Tucker MA, Greene MH, Clark WH Jr, et al: Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr 1983; 103:65–69.

    Article  PubMed  CAS  Google Scholar 

  44. Rigel DS, Friedman RJ, Kopf AW, et al: Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol 1986; 14:857–860.

    Article  PubMed  CAS  Google Scholar 

  45. MacKie RM: Which moles matter? The association between melanocytic naevi and malignant melanoma. Br J Dermatol 1981; 105:607–609.

    Article  PubMed  CAS  Google Scholar 

  46. MacKie RM: Multiple melanoma and atypical melanocytic naevi-evidence of an activated and expanded melanocytic system. Br J Dermatol 1982; 107:621–629.

    Article  PubMed  CAS  Google Scholar 

  47. Duray PH, Ernstoff MS: Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Arch Dermatol 1987; 123:80–84.

    Article  PubMed  CAS  Google Scholar 

  48. Lynch HT, Fusaro RM, Pester J, et al: Tumour spectrum in the FAMMM syndrome. Br J Cancer 1981; 44:553–560.

    Article  PubMed  CAS  Google Scholar 

  49. Albert DM, Chang MA, Lamping K, et al: The dysplastic nevus syndrome: A pedigree with primary malignant melanomas of the choroid and skin. Ophthalmology (Rochester) 1985; 92:1728–1734.

    PubMed  CAS  Google Scholar 

  50. Greene MH, Sanders RJ, Chu FC, et al: The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. Am J Ophthamol 1983; 96:238–245.

    CAS  Google Scholar 

  51. Eusebi V, Cook MG: Melanocytic dysplasia and internal malignancy. Clin Exp Dermatol 1986; 11:84–86.

    Article  PubMed  CAS  Google Scholar 

  52. Greene MH, Tucker MA, Clark WH Jr, et al: Hereditary melanoma and the dysplastic nevus syndrome: The risk of cancer other than melanoma. J Am Acad Dermatol 1987; 17:792–797.

    Article  Google Scholar 

  53. Dabski K, Milgrom H, Stoll HL: Dysplastic nevus syndrome: Association with multiple primary neoplasms. J Surg Oncol 1986; 32:113–120.

    Article  PubMed  CAS  Google Scholar 

  54. Holman CDJ, Armstrong BK: Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous melanoma. J Natl Cancer Inst 1984; 72:257–266.

    PubMed  CAS  Google Scholar 

  55. Rhodes AR, Fitzpatrick TB: Melanoma precursors: Risk factors and opportunities for prevention of cutaneous melanomas. J Dermatol Surg Oncol 1983; 9:672–673.

    Google Scholar 

  56. Lynch HT, Follett KL, Lynch PM, et al: Family history in an oncology clinic: Implications for cancer genetics. JAMA 1979; 242:1268–1272.

    Article  PubMed  CAS  Google Scholar 

  57. Tucker MA, Misfelt D, Coleman N, et al: Cutaneous malignant melanoma after Hodgkin’s disease. Ann Intern Med 1985; 102:37–41.

    PubMed  CAS  Google Scholar 

  58. MacKie RM, English JSC, Ashworth J, et al: Managing the dysplastic naevus. Lancet 1983; 2:1249–1250.

    Article  PubMed  CAS  Google Scholar 

  59. Day CL Jr, Mihm MC Jr, Sober AJ, et al: Skin lesions suspected to be melanoma should be photographed. JAMA 1982; 248:1077–1079.

    Article  PubMed  Google Scholar 

  60. Cassileth BR, Clark WH Jr, Heiberger RM, et al: Relationship between patients’ early recognition of melanoma and depth of invasion. Cancer 1982; 49:198–200.

    Article  PubMed  CAS  Google Scholar 

  61. Kopf AW, Gold RS, Rogers GS, et al: Relationship of lumbosacral nevocytic nevi to sun exposure in dysplastic nevus syndrome. Arch Dermatol 1986; 122:1003–1006.

    Article  PubMed  CAS  Google Scholar 

  62. Greene MH, Young TI, Clark WH: Malignant melanoma in renal-transplant recipients. Lancet 1981; 1:1196–1199.

    Article  PubMed  CAS  Google Scholar 

  63. Bondi EE, Clark WH Jr, Elder DE, et al: Topical chemotherapy of dysplastic nevi with 5-fluorouracil. Arch Dermatol 1980; 117:89–92.

    Article  Google Scholar 

  64. Meyskens FL, Edwards L, Levine NS: Role of topical tretinoin in melanoma and dysplastic nevi. J Am Acad Dermatol 1986; 15:822–825.

    Article  PubMed  Google Scholar 

  65. Swerdlow AJ, Green A: Melanocytic naevi and melanoma: An epidemiological perspective. Br J Dermatol 1987; 117:137–146.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. William A. Crutcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip J. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Crutcher, W.A., Cohen, P.J. (1988). The Dysplastic Nevus Syndrome. In: Skin Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3790-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3790-7_11

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-8352-2

  • Online ISBN: 978-1-4612-3790-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation